Los Angeles, CA – (Marketwired – April 26, 2016) – The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, has selected Saviynt to provide security administration, governance, and compliance management for its SAP NEXT program. As a company that is laser-focused on innovation and quality, this announcement follows the results of an extensive evaluation conducted by Merck KGaA, Darmstadt, Germany for a strategic security solutions partner.
Merck KGaA Darmstadt, Germany intends to leverage Saviynt for its enterprise-wide Identity Governance, Administration and Compliance (IGA and GRC) platform. Some of the salient features of the solution include:
- Privilege design and management for custom Fiori apps being developed on S/4HANA Automate deep Segregation of Duty (SOD) evaluation and remediation for multiple SAP and S/4HANA instances
- Enforce emergency/firefighter access management for SAP and SAP HANA
- Adopt a continuous controls monitoring framework and risk-based access certification Automate access life-cycle management with intelligent access request and provisioning policies across SAP, S/4HANA and AD systems
“We are excited about this partnership, in which we can offer privilege design and firefighter access management for Fiori and S/4HANA,” said Sachin Nayyar, CEO of Saviynt. “This solution showcases our vision of a single pane for securing SAP and non-SAP enterprise and cloud applications.”
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 72 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $130 billion global life science industry.
Merck KGaA, Darmstadt, Germany is a leading company for innovative and top-quality high- tech products in healthcare, life science, and performance materials. The company has six businesses — Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials — and generated sales of EUR 12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.
Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company — since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck KGaA, Darmstadt, Germany operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the U.S. and Canada.
Saviynt is an innovative leader in providing application, data, and infrastructure access governance and intelligence platform for Cloud and Enterprise. Saviynt uniquely delivers IGA 2.0 by integrating advanced usage & risk analytics with fine-grained privilege management. Saviynt’s completely managed IDaaS platform ensures a worry-free adoption of IGA services to secure critical enterprise assets. Visit Saviynt.com
For more information, please contact